MitoGENE Technologies

MitoGENE Technologies Global medicine supplier | FDA/EMA-approved therapies via Named Patient Program | Generics & APIs for advanced treatments worldwide.

Need Access to TRUQAP (Capivasertib) in India?MitoGENE helps patients access TRUQAP safely through CDSCO Named Patient P...
09/03/2026

Need Access to TRUQAP (Capivasertib) in India?

MitoGENE helps patients access TRUQAP safely through CDSCO Named Patient Program.

End-to-end support — documentation, import & delivery under doctor supervision.

👉 Learn how to access treatment now

🔗 https://mitogene.org/products/truqap-capivasertib/

Celebrating the strength, resilience, and compassion of women who inspire hope and create impact every day. Honoring the...
08/03/2026

Celebrating the strength, resilience, and compassion of women who inspire hope and create impact every day.

Honoring their courage, care, and contribution to a healthier and stronger world.

Happy International Women’s Day.

Need access to Truqap (Capivasertib) in India?For patients with advanced breast cancer, treatment availability can somet...
05/03/2026

Need access to Truqap (Capivasertib) in India?
For patients with advanced breast cancer, treatment availability can sometimes be a challenge.
When a medicine like Truqap is not commercially available locally, patients may still obtain it through the Named Patient Program under physician supervision.
MitoGENE helps simplify the process by supporting:
✔ CDSCO documentation and approvals
✔ Global medicine sourcing
✔ Safe and compliant delivery to patients
Learn how to access Truqap in India and understand the full process.
Read the complete guide here:
https://mitogene.org/accessing-truqap-capivasertib-in-india-for-advanced-breast-cancer/

How to access global medicine for cancer care in India.Eligible patients may access ORSERDU through a structured and com...
02/03/2026

How to access global medicine for cancer care in India.
Eligible patients may access ORSERDU through a structured and compliant pathway under the CDSCO Named Patient Program.
Read the complete guide here:
🔗 https://mitogene.org/orserdu

Accessing advanced breast cancer therapies in India can be challenging.MitoGENE simplifies the process by guiding patien...
24/02/2026

Accessing advanced breast cancer therapies in India can be challenging.
MitoGENE simplifies the process by guiding patients through approvals, sourcing, and delivery with trusted support.
Learn more here:
👉 https://mitogene.org/orserdu/

Orserdu is recommended for certain breast cancer cases but is not sold in India.Patients can still access it legally thr...
20/02/2026

Orserdu is recommended for certain breast cancer cases but is not sold in India.
Patients can still access it legally through the CDSCO Named Patient Program with MitoGENE’s support.

Read the full details: https://mitogene.org/orserdu/

Contact MitoGENE for guidance.

Address

No:7, Plot:47/1, Selvaraj Nagar, Extn – 2, Urapakkam West
Chennai
603211

Opening Hours

Monday 10am - 5am
Tuesday 10am - 5am
Thursday 10am - 5am
Friday 10am - 5am

Website

Alerts

Be the first to know and let us send you an email when MitoGENE Technologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category